| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Schmidt Eric Thomas is a Chief Financial Officer at Allogene Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2022 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 11,469 | $7.63 | $87,550.91 | -10.2% | +13.5% | -27.4% | |
| Mar 15, 2021 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 8,053 | $38.23 | $307,888.74 | -10.2% | -35.0% | -80.0% | |
| Jan 15, 2021 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 30,000 | $31.52 | $945,469.15 | -0.5% | - | - | |
| Nov 16, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 15,000 | $32.88 | $493,146.40 | -0.6% | - | - | |
| Oct 15, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 15,000 | $40.49 | $607,392.37 | -0.2% | - | - | |
| Sep 21, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 15,000 | $35.30 | $529,544.76 | -0.4% | - | - | |
| Mar 16, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 5,450 | $19.73 | $107,507.86 | -5.4% | - | - |